Back to Search
PAUL LYLE, M.D.
M.D.
Diagnostic Radiology Physician
NPI: 1427131093IndividualAccepts Medicare
Specialties, Licenses & Credentials
Diagnostic Radiology PhysicianPrimary
Radiology — Diagnostic Radiology
Code: 2085R0202X
4301075600(MI)
CMS Specialties
PrimaryDIAGNOSTIC RADIOLOGY
Education
UNIVERSITY OF MINNESOTA MEDICAL SCHOOL
Class of 1996
Research & Publications (20)
Effects of losartan compared with atenolol on lipids in patients with hypertension and left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension study.
PMID 19262226·J Hypertens·2009
8-other
A double-blind, randomized study evaluating losartan potassium monotherapy or in combination with hydrochlorothiazide versus placebo in obese patients with hypertension.
PMID 18328120·Curr Med Res Opin·2008
4-observational
The left atrium, atrial fibrillation, and the risk of stroke in hypertensive patients with left ventricular hypertrophy.
PMID 19124445·Ther Adv Cardiovasc Dis·2008
6-review
Effects of losartan in women with hypertension and left ventricular hypertrophy: results from the Losartan Intervention for Endpoint Reduction in Hypertension Study.
PMID 18259029·Hypertension·2008
2-rct
Lymphoepithelioma-like carcinoma arising in the scar from a previously excised basal cell carcinoma.
PMID 18201243·J Cutan Pathol·2008
5-case
ACE gene polymorphism and losartan treatment in type 2 diabetic patients with nephropathy.
PMID 18199798·J Am Soc Nephrol·2008
2-rct
The effect of losartan on hemoglobin concentration and renal outcome in diabetic nephropathy of type 2 diabetes.
PMID 18094675·Kidney Int·2008
2-rct
Gastrointestinal melanoma or clear cell sarcoma? Molecular evaluation of 7 cases previously diagnosed as malignant melanoma.
PMID 18408594·Am J Surg Pathol·2008
8-other
Effect of LDL cholesterol and treatment with losartan on end-stage renal disease in the RENAAL study.
PMID 18070995·Diabetes Care·2008
8-other
Clusters of metabolic risk factors predict cardiovascular events in hypertension with target-organ damage: the LIFE study.
PMID 17476291·J Hum Hypertens·2007
8-other
The effect of baseline physical activity on cardiovascular outcomes and new-onset diabetes in patients treated for hypertension and left ventricular hypertrophy: the LIFE study.
PMID 17875180·J Intern Med·2007
4-observational
Effect of hemoglobin levels on cardiovascular outcomes in patients with isolated systolic hypertension and left ventricular hypertrophy (from the LIFE study).
PMID 17719333·Am J Cardiol·2007
4-observational
Fixed combination of losartan and hydrochlorothiazide and reduction of risk of stroke.
PMID 17703637·Vasc Health Risk Manag·2007
6-review
Atenolol as a comparator in outcome trials in hypertension: a correct choice in the past, but not for the future?
PMID 17453746·Blood Press·2007
1-meta
Use of beta-blockers, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers to prevent atrial fibrillation.
PMID 16956451·Curr Cardiol Rep·2006
6-review
Risk scores for predicting outcomes in patients with type 2 diabetes and nephropathy: the RENAAL study.
PMID 17699284·Clin J Am Soc Nephrol·2006
8-other
A multicenter, randomized, double-blind, parallel-group trial of the antihypertensive efficacy and tolerability of a combination of once-daily losartan 100 mg/hydrochlorothiazide 12.5 mg compared with losartan 100-mg monotherapy in the treatment of mild to severe essential hypertension.
PMID 17157119·Clin Ther·2006
4-observational
Steroid receptor coactivator AIB1 in endometrial carcinoma, hyperplasia and normal endometrium: Correlation with clinicopathologic parameters and biomarkers.
PMID 16980945·Mod Pathol·2006
8-other
The effect of losartan compared with atenolol on the incidence of revascularization in patients with hypertension and electrocardiographic left ventricular hypertrophy. The LIFE study.
PMID 16572193·J Hum Hypertens·2006
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 500 CAMPUS DR
HANCOCK, MI 49930 - Phone
- (906) 360-3014
Quick Facts
- NPI
- 1427131093
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 30
- Publications
- 20
Are you this provider?
Claim Your Profile